Agarwal Arjun — SEC Form 4 filings
SEC reporting owner CIK 2033974. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2025-01-24 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 25 legs across 7 filings — 52,144 shares, $4,278,386 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 5,656 shares @ $84.90 ($480,201) in Oruka Therapeutics, Inc., filed 2026-07-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | 9 | — | 25 legs · 52,144 sh · $4,278,386 | 23 |
Form 4 filings — Agarwal Arjun
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 8,000 @ $12.50 · Option exercise (M): 1,459 @ $34.39 · Sale (S): 3,000 @ $91.11 · Sale (S): 4,051 @ $92.41 · Sale (S): 2,208 @ $93.26 · Sale (S): 200 @ $94.02 · +3 more | EDGAR |
| 2026-08-14 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 8,542 @ $12.50 · Option exercise (M): 1,458 @ $34.39 · Sale (S): 2,100 @ $104.67 · Sale (S): 2,132 @ $105.57 · Sale (S): 1,268 @ $106.63 · Sale (S): 2,142 @ $107.71 · +3 more | EDGAR |
| 2026-07-13 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 8,541 @ $12.50 · Option exercise (M): 1,458 @ $34.39 · Sale (S): 300 @ $83.07 · Sale (S): 3,743 @ $84.26 · Sale (S): 5,656 @ $84.90 · Sale (S): 300 @ $85.63 · +2 more | EDGAR |
| 2026-06-22 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 888 @ $80.01 · Sale (S): 699 @ $82.14 | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 8,000 @ $12.50 · Option exercise (M): 1,459 @ $34.39 · Sale (S): 1,859 @ $68.34 · Sale (S): 4,340 @ $69.85 · Sale (S): 3,260 @ $70.34 · Sale (S): 395 @ $69.69 · +2 more | EDGAR |
| 2026-05-18 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 2,000 @ $12.50 · Option exercise (M): 5,833 @ $34.39 · Sale (S): 4,190 @ $58.34 · Sale (S): 4,600 @ $59.19 · Sale (S): 800 @ $60.34 · Sale (S): 700 @ $61.16 · +2 more | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 395 @ $41.30 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 17,500 @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2033974 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →